Nasdaq:US$13.39 (+1.18) | HKEX:HK$19.90 (-0.25) | AIM:£2.09 (-0.1)
News & Presentations
Previous Article   |   Next Article
Presentations | 6 Jun 2022

ASCO2022: Surufatinib in US Patients with Soft Tissue Sarcoma